PETKANAS DEAN enters NEUROPATHIX, INC. with 21.46M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 8/7/2018ACC: 0001078782-18-000799
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2018
21.46M
Baseline shares
95% direct
20.34M
Direct ownership
1 position
75K
Derivative underlying
1 instrument
3
Security positions
1.12M indirect
Non-Derivative Holdings3
Common Stock
IndirectShares owned600K
Common Stock
IndirectShares owned518.10K
Common Stock
DirectShares owned20.34M
Total
20.34M direct·1.12M indirect21.46M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 600K | Indirect |
| Common Stock | 518.10K | Indirect |
| Common Stock | 20.34M | Direct |
| Total | 21.46M | 20.34M direct·1.12M indirect |
Derivative Holdings1
Series B Convertible Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
75K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
75K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series B Convertible Preferred Stock Direct | Common Stock | — | — | 75K | N/A | |
| Total | 75K | 0.00 | ||||